Medtronic Cardiac Rhythm and Heart Failure
Works in Cardiovascular · Metabolic & endocrine · Neurology · Respiratory
Medtronic Cardiac Rhythm and Heart Failure is a clinical trial sponsor. It has 12 active clinical trials with 8,634 planned participants, in Cardiovascular, Metabolic & endocrine, Neurology and Respiratory. Since 2021 it has completed 81 trials and stopped 15 early.
Trial track record · since 2021
Pipeline · 12 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Medtronic Cardiac Rhythm and Heart Failure
Medtronic Cardiac Rhythm and Heart Failure is lead sponsor of 12 active clinical trials on ClinicalTrials.gov, with 8,634 planned participants, in Cardiovascular, Metabolic & endocrine, Neurology, Respiratory. Since 2021 it has completed 81 trials and stopped 15 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Medtronic Cardiac Rhythm and Heart Failure; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
Approve Suite is not affiliated with Medtronic Cardiac Rhythm and Heart Failure.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.